Press release – New conditioning therapy by medac about to receive European approval
Positive opinion from the CHMP for TRECONDI® (treosulfan) by medac for toxicity-reducing conditioning for allogeneic haematopoietic stem cell transplantation.
Medac has received the Yellow Hand Award
Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in 2011.
Medac has used this labelling for more than 2 years and the aim of this label is to sensitize all personnel involved in transportation and to protect involved personnel from possible contamination during handling of our products.
